---
title: "16:24 ETCleveland Medical Devices Reports Favorable PTAB Outcomes in Five of Six ResMed IPR Challenges"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292528027.md"
description: "Cleveland Medical Devices announced favorable outcomes in five of six inter partes review (IPR) challenges filed by ResMed before the Patent Trial and Appeal Board (PTAB). In four proceedings, the PTAB ruled that ResMed failed to prove the challenged claims unpatentable, while in one, the petition was denied. ResMed won only one proceeding. These results bolster Cleveland Medical Devices' intellectual property portfolio, though district court litigation regarding infringement remains pending."
datetime: "2026-07-13T20:26:52.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292528027.md)
  - [en](https://longbridge.com/en/news/292528027.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292528027.md)
---

# 16:24 ETCleveland Medical Devices Reports Favorable PTAB Outcomes in Five of Six ResMed IPR Challenges

, /PRNewswire/ -- Cleveland Medical Devices Inc. announced that proceedings before the Patent Trial and Appeal Board have now produced favorable outcomes for Cleveland Medical Devices in five of the six inter partes review petitions filed by ResMed against patents involved in the parties' Ohio litigation.

In four of the five proceedings that reached final written decisions, the PTAB determined that ResMed had not established that the challenged claims were unpatentable. In a fifth proceeding, the PTAB denied institution of ResMed's petition. ResMed obtained a favorable final written decision in one proceeding.

"These are important results for Cleveland Medical Devices and its intellectual-property portfolio," said Robert N. Schmidt, Chairman and Chief Executive Officer of Cleveland Medical Devices. "We are pleased that numerous challenged patent claims have survived ResMed's PTAB challenges over the cited prior art."

The PTAB proceedings addressed patentability and did not decide infringement, damages, or other issues pending in the district-court litigations. Cleveland Medical Devices' district-court cases against ResMed remain pending and involve alleged infringement of Cleveland Medical Devices' CPAP and home-sleep-testing patents.

The Ohio PTAB results are separate from Cleveland Medical Devices' pending Delaware litigation involving additional home-sleep-testing patents. Those patents were not involved in the six Ohio IPR proceedings.

Cleveland Medical Devices has 44 patents covering sleep testing and sleep therapy.

Cleveland Medical Devices intends to continue enforcing its intellectual-property rights while respecting all pending judicial and administrative proceedings.

For Further Information Contact:  
Robert N. Schmidt, PE, MS, MBA, JD  
Founder and Chairman  
Cleveland Medical Devices Inc.  
216-374-7237  
\[email protected\]

SOURCE Cleveland Medical Devices Inc.

### Related Stocks

- [RMD.US](https://longbridge.com/en/quote/RMD.US.md)
- [RMD.AU](https://longbridge.com/en/quote/RMD.AU.md)

## Related News & Research

- [Royal Bank of Canada Reduces Stock Holdings in ResMed Inc. $RMD](https://longbridge.com/en/news/294602242.md)
- [How Investors Are Reacting To ResMed (RMD) Downgrade Amid FY27 Cost and Supply Pressures](https://longbridge.com/en/news/293088548.md)
- [Impinj’s Licensing Model Exposes Material Risk: Limited IP Monetization Experience and Heavy Reliance on NXP Threaten Revenue Stability](https://longbridge.com/en/news/294465416.md)
- [Sadot Group restructures Anira deal into USD 11.5 million TradeOS asset acquisition](https://longbridge.com/en/news/294413941.md)
- [09:30 ETSmart Vending Machine Supplier HALOO Reaches 100+ Intellectual Property Milestone and Serves Markets Across 100+ Countries](https://longbridge.com/en/news/294216155.md)